Overview
Bartter syndrome is a group of rare inherited renal tubular disorders characterized by impaired salt reabsorption in the thick ascending limb of the loop of Henle in the kidneys. This leads to a distinctive set of metabolic abnormalities including hypokalemia (low potassium), hypochloremic metabolic alkalosis (elevated blood pH with low chloride), hyperreninemia, and hyperaldosteronism with normal to low blood pressure. The condition primarily affects the kidneys but has widespread consequences for the cardiovascular, muscular, and skeletal systems. Several subtypes of Bartter syndrome have been identified (types I through V), each caused by mutations in different genes involved in ion transport in the kidney. Type I is caused by mutations in SLC12A1 (encoding the NKCC2 cotransporter), type II by KCNJ1 (ROMK potassium channel), type III by CLCNKB (chloride channel Kb), type IVa by BSND (barttin), type IVb by combined CLCNKA and CLCNKB mutations, and type V by MAGED2 mutations. The antenatal/neonatal forms (types I, II, IV, and V) typically present with polyhydramnios, premature birth, life-threatening salt and water loss, polyuria, and failure to thrive. Type III, also known as classic Bartter syndrome, generally presents in infancy or early childhood with less severe symptoms including growth retardation, muscle weakness, cramps, fatigue, and salt craving. Some subtypes, particularly type IV, may also be associated with sensorineural deafness. Treatment is supportive and aimed at correcting electrolyte imbalances and minimizing complications. This typically includes potassium and magnesium supplementation, nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin to reduce renal prostaglandin production and improve electrolyte reabsorption, and potassium-sparing diuretics such as spironolactone or amiloride. ACE inhibitors may also be used in some cases. With appropriate lifelong management, many patients can achieve improved growth and quality of life, though careful monitoring of renal function and electrolytes remains essential.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Bartter syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Bartter syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Bartter syndrome.
Community
No community posts yet. Be the first to share your experience with Bartter syndrome.
Start the conversation →Latest news about Bartter syndrome
No recent news articles for Bartter syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Bartter syndrome
What is Bartter syndrome?
Bartter syndrome is a group of rare inherited renal tubular disorders characterized by impaired salt reabsorption in the thick ascending limb of the loop of Henle in the kidneys. This leads to a distinctive set of metabolic abnormalities including hypokalemia (low potassium), hypochloremic metabolic alkalosis (elevated blood pH with low chloride), hyperreninemia, and hyperaldosteronism with normal to low blood pressure. The condition primarily affects the kidneys but has widespread consequences for the cardiovascular, muscular, and skeletal systems. Several subtypes of Bartter syndrome have b
How is Bartter syndrome inherited?
Bartter syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Bartter syndrome?
18 specialists and care centers treating Bartter syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.